Copaxone
 | This article is a stub. |
Copaxone or glatopa, and glatiramer, its generic form, is a drug licensed to reduce relapses in patients with multiple sclerosis.[1]
Contents
ME/CFS[edit | edit source]
Ron Davis of the Open Medicine Foundation reports that when the nanoneedle electrical impedance test on ME/CFS cells was used, Copaxone made the cells respond in the same way as healthy cells did, suggesting it is a potential treatment for ME/CFS.[2]
See also[edit | edit source]
Learn more[edit | edit source]
- Copaxone - drugs.com
References[edit | edit source]
- ↑ "Copaxone: Uses, Dosage, Side Effects". Drugs.com. Retrieved April 30, 2019.
- ↑ Davis, Ron (September 2019). "Dr. Ron Davis Presents on ME/CFS Research Activities at Stanford at Inaugural Harvard Symposium". Retrieved September 8, 2019.
nanoneedle A device with microscopic dimensions which measures electrical impedance across a blood cell. According to Ron Davis, the nanoneedle measured increased electrical impedance in the blood cells of 10 ME/CFS patients when stressed with salt, but not in healthy controls. Accordingly, this device has been proposed as a potential diagnostic test to distinguish ME/CFS patients from healthy controls. (Learn more: www.omf.ngo)
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
